TNF Pharmaceuticals (TNFA) Competitors $1.18 +0.02 (+1.29%) As of 01/21/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsTrends TNFA vs. CING, NERV, PRPH, SPRB, HCWB, NRSN, IMNN, BGXX, AIM, and FLGCShould you be buying TNF Pharmaceuticals stock or one of its competitors? The main competitors of TNF Pharmaceuticals include Cingulate (CING), Minerva Neurosciences (NERV), ProPhase Labs (PRPH), Spruce Biosciences (SPRB), HCW Biologics (HCWB), NeuroSense Therapeutics (NRSN), Imunon (IMNN), Bright Green (BGXX), AIM ImmunoTech (AIM), and Flora Growth (FLGC). These companies are all part of the "pharmaceutical products" industry. TNF Pharmaceuticals vs. Cingulate Minerva Neurosciences ProPhase Labs Spruce Biosciences HCW Biologics NeuroSense Therapeutics Imunon Bright Green AIM ImmunoTech Flora Growth Cingulate (NASDAQ:CING) and TNF Pharmaceuticals (NASDAQ:TNFA) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, community ranking, risk, profitability, valuation and earnings. Does the media refer more to CING or TNFA? In the previous week, TNF Pharmaceuticals had 1 more articles in the media than Cingulate. MarketBeat recorded 1 mentions for TNF Pharmaceuticals and 0 mentions for Cingulate. TNF Pharmaceuticals' average media sentiment score of 1.52 beat Cingulate's score of 0.00 indicating that TNF Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Cingulate Neutral TNF Pharmaceuticals Very Positive Do insiders and institutionals hold more shares of CING or TNFA? 41.3% of Cingulate shares are held by institutional investors. Comparatively, 9.6% of TNF Pharmaceuticals shares are held by institutional investors. 17.1% of Cingulate shares are held by insiders. Comparatively, 1.2% of TNF Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has higher earnings and valuation, CING or TNFA? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCingulateN/AN/A-$23.53MN/AN/ATNF PharmaceuticalsN/AN/A-$4MN/AN/A Is CING or TNFA more profitable? TNF Pharmaceuticals' return on equity of -180.71% beat Cingulate's return on equity.Company Net Margins Return on Equity Return on Assets CingulateN/A -570.20% -236.15% TNF Pharmaceuticals N/A -180.71%-84.27% Which has more risk & volatility, CING or TNFA? Cingulate has a beta of -0.84, indicating that its stock price is 184% less volatile than the S&P 500. Comparatively, TNF Pharmaceuticals has a beta of 2.15, indicating that its stock price is 115% more volatile than the S&P 500. Do analysts rate CING or TNFA? Cingulate presently has a consensus target price of $12.00, indicating a potential upside of 148.96%. Given Cingulate's stronger consensus rating and higher possible upside, research analysts plainly believe Cingulate is more favorable than TNF Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cingulate 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33TNF Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community favor CING or TNFA? Cingulate received 9 more outperform votes than TNF Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformCingulateOutperform Votes975.00% Underperform Votes325.00% TNF PharmaceuticalsN/AN/A SummaryCingulate beats TNF Pharmaceuticals on 7 of the 13 factors compared between the two stocks. Get TNF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNFA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNFA vs. The Competition Export to ExcelMetricTNF PharmaceuticalsDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.24M$2.17B$5.39B$9.13BDividend YieldN/A0.66%5.37%4.00%P/E RatioN/A5.1788.8317.53Price / SalesN/A92.771,280.48134.21Price / CashN/A16.2336.6032.90Price / Book0.163.434.964.69Net Income-$4M$29.98M$117.89M$224.57M7 Day Performance-0.42%2.75%1.67%1.69%1 Month Performance-13.60%-0.85%3.62%5.34%1 Year PerformanceN/A-16.38%26.15%21.47% TNF Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNFATNF PharmaceuticalsN/A$1.18+1.3%N/AN/A$3.24MN/A0.006Positive NewsCINGCingulate2.422 of 5 stars$4.63-3.7%$12.00+159.2%+6.6%$14.87MN/A0.0020NERVMinerva Neurosciences3.3536 of 5 stars$2.12-2.8%$5.00+135.8%-71.0%$14.83MN/A-4.829Analyst ForecastNews CoverageGap DownPRPHProPhase Labs3.3838 of 5 stars$0.61-5.8%$11.00+1,699.7%-87.7%$14.59M$12.75M-0.49130SPRBSpruce Biosciences3.5956 of 5 stars$0.35-4.7%$3.90+1,006.4%-84.4%$14.56M$7.10M-0.3720Gap UpHCWBHCW Biologics1.5863 of 5 stars$0.38+2.4%N/A-68.2%$14.37M$3.50M-0.3840NRSNNeuroSense Therapeutics0.6885 of 5 stars$1.02-1.9%N/A+17.7%$13.94MN/A-1.2010IMNNImunon1.9869 of 5 stars$0.93+3.5%$20.50+2,101.9%+57.3%$13.50M$500,000.00-0.4930Short Interest ↑BGXXBright GreenN/A$0.07+3.2%N/A-66.7%$13.48MN/A-1.182AIMAIM ImmunoTech1.8325 of 5 stars$0.21-3.3%$2.75+1,222.1%-47.8%$13.27M$190,000.00-0.4420FLGCFlora Growth2.1717 of 5 stars$0.92-4.6%$5.00+445.9%-45.0%$13.22M$64.15M0.00280 Related Companies and Tools Related Companies Cingulate Alternatives Minerva Neurosciences Alternatives ProPhase Labs Alternatives Spruce Biosciences Alternatives HCW Biologics Alternatives NeuroSense Therapeutics Alternatives Imunon Alternatives Bright Green Alternatives AIM ImmunoTech Alternatives Flora Growth Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TNFA) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TNF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TNF Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
